Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A drug that may cost millions of pounds per patient has been given the green light for use on the NHS.
The NHS drug advisory body, NICE, said eculizumab could give people with a rare life-threatening blood disorder an extra 25 years of life.
It can also prevent patients from needing dialysis or kidney transplants.
The therapy was evaluated through a special programme for extremely rare conditions, bypassing the usual value-for-money calculations.
Some 200 people in England suffer from atypical haemolytic uraemic syndrome and 20-30 new patients are diagnosed with the condition each year.
Around one in 10 die in the initial acute stages of the disease.
http://www.bbc.co.uk/news/health-31019090
The NHS drug advisory body, NICE, said eculizumab could give people with a rare life-threatening blood disorder an extra 25 years of life.
It can also prevent patients from needing dialysis or kidney transplants.
The therapy was evaluated through a special programme for extremely rare conditions, bypassing the usual value-for-money calculations.
Some 200 people in England suffer from atypical haemolytic uraemic syndrome and 20-30 new patients are diagnosed with the condition each year.
Around one in 10 die in the initial acute stages of the disease.
http://www.bbc.co.uk/news/health-31019090